Johnson & Johnson Q3
This article was originally published in The Rose Sheet
Executive Summary
Worldwide skin care sales advance 15% to $390 mil. in third quarter, led by Neutrogena, Aveeno, Clean & Clear brands, firm says in 1Oct. 15 sales and earnings release. Skin care sales in the U.S. rose 13% to $170 mil. and were up 17% to $169 mil. in international markets. "Continued strength of the overall product line, momentum associated with a broad range of new product offerings launched earlier this year and expanded growth of these equities outside the U.S. were the key drivers" of growth, according to J&J. Baby and kids care sales rose 4% worldwide to $300 mil., reflecting strong sales outside the U.S. of skin care and wipes products. Domestic baby care sales declined 3% to $68 mil., depressed by divestiture of Healthflow and Sippy Cup businesses...